12 . December , 2018 - Wednesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Linezolid

Big Image Pronouncation: (lin-EH-zoe-lid)
Class: Oxalodinones

Trade Names:
- Tablets 400 mg (sodium content is 1.95 mg per 400 mg tablet [0.1 mEq/tablet])
- Tablets 600 mg (sodium content is 2.92 mg per 600 mg tablet [0.1 mEq/tablet])
- Powder for oral suspension 100 mg per 5 mL (sodium content is 8.52 mg per 5 mL [0.4 mEq per 5 mL])
- Injection 2 mg/mL (sodium content is 0.38 mg/mL [5 mEq per 300 mL bag, 3.3 mEq per 200 mL bag, 1.7 mEq per 100 mL bag])

Zyvoxam (Canada)
Zyvoxam IV (Canada)

Mechanism of Action


Prevents the formation of a functional 70S initiation complex, which is essential to the bacterial translation process.



Rapidly and extensively absorbed. T max is 1 to 2 h. Absolute bioavailability is about 100% (no dose adjustment needed from IV to oral). Food does not affect absorption; however, T max is delayed from 1.5 to 2.2 h and C max is decreased 17% when high-fat food is given.


Readily distributed to well-perfused tissues; 31% protein bound. Vd at steady state is 40 to 50 L.


Primarily metabolized by oxidation of the morpholine ring. Metabolites are aminoethoxyacetic acid (A) and hydroxyethyl glycine (B) metabolite.


About 65% nonrenal Cl. Approximately 30% of dose appears in urine (40% as metabolite B, 10% as metabolite A). Renal Cl is 40 mL/min.

Indications and Usage

Treatment of vancomycin-resistant Enterococcus faecium infections; treatment of nosocomial pneumonia, complicated and uncomplicated skin and skin structure infections, and community-acquired pneumonia caused by susceptible strains of specific organisms.


Standard considerations.

Dosage and Administration

No dosage adjustment is necessary when switching from IV to PO. Administer IV infusion over a period of 30 to 120 min.

Vancomycin-Resistant E. faecium Infections, Including Concomitant Bacteremia
Adults and children 12 yr of age and older

PO or IV 600 mg every 12 h for 14 to 28 days.

Children (birth through 11 yr of age)

PO or IV 10 mg/kg every 8 h for 14 to 28 days. Most preterm neonates younger than 7 days of age should start with 10 mg/kg every 12 h. A dose of 10 mg/kg every 8 h may be considered in neonates with a suboptimal response.

Nosocomial Pneumonia, Complicated Skin and Skin Structure Infections, Community-Acquired Pneumonia, Including Concomitant Bacteremia
Adults and children 12 yr of age and older

PO or IV 600 mg every 12 h for 10 to 14 days.

Children (birth through 11 yr of age)

PO or IV 10 mg/kg every 8 h for 10 to 14 days. Most preterm neonates less than 7 days of age should start with 10 mg/kg every 12 h. A dose of 10 mg/kg every 8 h may be considered in neonates with a suboptimal response.

Uncomplicated Skin and Skin Structure Infections

PO 400 mg every 12 h for 10 to 14 days.

Children 12 to 18 yr of age

PO 600 mg every 12 h for 10 to 14 days.

Children 5 to 11 yr of age

PO 10 mg/kg every 12 h for 10 to 14 days.

Children younger than 5 yr of age

PO 10 mg/kg every 8 h for 10 to 14 days. Most preterm neonates younger than 7 days of age should start with 10 mg/kg every 12 h. A dose of 10 mg/kg every 8 h may be considered in neonates with a suboptimal response.

Methicillin-Resistant Staphylococcus aureus

600 mg every 12 h.

General Advice

  • Oral suspension contains phenylalanine. Do not administer oral suspension to patient with phenylketonuria without first discussing with health care provider.
  • Administer tablets and oral suspension without regard to meals. Administer with food if GI upset occurs.
  • Gently mix suspension by inverting bottle 3 to 5 times before each dose. Do not shake suspension. Measure and administer prescribed dose of suspension using dosing syringe, dosing spoon, or dosing cup.
  • Suspension may be used in adults with swallowing problems.
  • For administration by intermittent IV infusion only. Not for intradermal, subcutaneous, IM, continuous IV infusion, IV bolus, or intra-arterial administration.
  • Keep infusion bag in protective overwrap until ready to administer.
  • Do not administer if solution is cloudy, discolored, or contains particulate matter. Solution may exhibit a yellow color, which is normal and does not affect potency.
  • Before administration, check IV bag for minute leaks by firmly squeezing bag. If leaks are detected, discard solution as sterility may be compromised.
  • Do not use IV infusion bag in series connections nor add any other medications to infusion bag.
  • If other drugs are being administered through same IV line, flush IV line before and after infusion of linezolid with dextrose 5% injection, sodium chloride 0.9% injection, or lactated Ringer's injection.



Store tablets and reconstituted suspension at controlled room temperature (59° to 86°F). Protect from light. Keep bottles tightly closed. Discard any unused suspension after 21 days.


Store IV infusion bags at controlled room temperature (59° to 86°F). Protect infusion bags from freezing and light.

Drug Interactions

Adrenergic agents (eg, dopamine, epinephrine)

Effects may be enhanced by linezolid.

Serotonergic agents (eg, fluoxetine)

Possible increased risk of serotonin syndrome.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Headache (7%); insomnia, convulsions (3%); dizziness (2%); vertigo (1%); neuropathy (postmarketing).


Rash (7%); skin disorder (2%).


Pharyngitis (3%).


Diarrhea (11%); vomiting (9%); nausea (6%); generalized and localized abdominal pain, GI bleeding, loose stools, constipation, altered taste (2%); tongue discoloration, oral moniliasis (1%).


Vaginal moniliasis (2%).


Anemia (6%); thrombocytopenia (5%); thrombocythemia (3%); eosinophilia (1%); leukopenia, pancytopenia (postmarketing).

Lab Tests

Abnormal LFTs (1%).


Hypokalemia (3%); generalized edema (2%); lactic acidosis (postmarketing).


Upper respiratory tract infection (4%); pneumonia, dyspnea (3%); cough, apnea (2%).


Fever (14%); sepsis (8%); trauma, injection site reactions (3%); fungal infections, localized pain (2%).



Category C .




See dosing recommendations.

Lactic acidosis

May occur.


Because myelosuppression has been reported, monitor CBC weekly in patients receiving linezolid.

Pseudomembranous colitis

Consider pseudomembranous colitis in patients who develop diarrhea.

Patient Information

  • Review dosing schedule and prescribed length of therapy with patient. Advise patient that dose and duration of therapy are dependent on site and cause of infection and response to treatment.
  • Advise patient or caregiver that injection is used when infection is severe and needs immediate treatment with large doses of antibiotic, or if oral therapy is not feasible. Advise patient or caregiver that injection will be prepared by a health care professional, administered in a health care setting, and oral therapy will be started as soon as possible.
  • Advise patient to take each dose without regard to meals but to take with food if stomach upset occurs.
  • Advise patient or caregiver to gently mix suspension by inverting bottle 3 to 5 times before measuring dose, then measure and administer prescribed dose using a dosing syringe, dosing spoon, or dosing cup.
  • Reinforce the need to take exactly as prescribed and complete entire course of therapy, even if symptoms of infection have disappeared. Caution patient or caregiver that skipping doses or not completing the full course of therapy may cause the infection to worsen and increase the possibility that the bacteria will become resistant to the antibiotic and may cause infections that will not be treatable in the future.
  • Instruct patient to avoid foods and beverages with high tyramine content. Review common foods known to have high tyramine content (eg, aged cheeses, soy sauce, fermented or air-dried meats, sauerkraut, tap beers, red wines).
  • Advise patient that diarrhea, headache, and nausea are most common adverse reactions and to inform health care provider if they occur and are intolerable.
  • Advise patient to discontinue therapy and contact health care provider immediately if skin rash, hives, itching, general body discomfort, muscle aches, unexplained rapid breathing or shortness of breath, progressive drowsiness, or generalized stomach distress occurs.
  • Advise patient to report signs of superinfection to health care provider: black, furry tongue, white patches in mouth, foul-smelling stools, vaginal itching or discharge.
  • Warn patient that diarrhea containing blood or pus may be a sign of a serious disorder and to seek medical care if noted and not treat at home even if diarrhea starts after stopping the antibiotic.
  • Caution patient not to take any OTC cold products containing decongestants (eg, pseudoephedrine) unless advised by health care provider.

Recent Drug Updates at DrugIndexOnline:

Auranofin Auranofin
Some commonly used brand names are: In the U.S.— Myochrysine 3 Ridaura 1 Solganal 2 In Canada— Myochrysine 3 Ridaura 1 Note: For quick reference, the following gold compounds are numbered to match the corresponding brand names. This information applies to the following more...

cefepime cefepime
Generic Name: cefepime Brand Names: Maxipime What is cefepime? Cefepime is an antibiotic in a class of drugs called cephalosporins. Cefepime fights bacteria in the body. Cefepime is used to treat many different types of bacterial infections including respiratory, skin, genital, urinary, more...

Emtricitabine/Tenofovir Emtricitabine/Tenofovir
Generic Name: Emtricitabine/Tenofovir (em-trih-SYE-ta-bean/te-NOE-fo-veer) Brand Name: TruvadaLactic acidosis (buildup of an acid in the blood) has been reported with this type of medicine. Notify your doctor immediately if you experience extreme weakness or tiredness; unusual muscle pain; diffi more...

fluorometholone ophthalmic fluorometholone ophthalmic
Generic Name: fluorometholone ophthalmic (flure oh METH oh lone) Brand Names: Eflone, Flarex, Fluor-Op, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. What is fluorometholone ophthalmic? Fluorometholone is a steroid medicine. It prevents the release of substances in the body that cause more...

Isovue Isovue
Generic Name: iopamidol Dosage Form: Injection, solution NOT FOR INTRATHECAL USE Isovue 200, 250, 300 and 370 are NOT FOR INTRATHECAL USE.See Indications, and Dosage and Administration sections for further detailson proper use DIAGNOSTICNONIONIC RADIOPAQUE CONTRAST MEDIAFor Angiography Thr more...

Maalox Maalox
Brand names: Gaviscon, Maalox, Mylanta, Rolaids, Tums Why is Maalox prescribed? Available under a number of brand names, antacids are used to relieve the uncomfortable symptoms of acid indigestion, heartburn, gas, and sour stomach. Most important fact about Maalox Do not take antacids for longe more...

Ocu-Phrin Sterile Eye Drops Ophthalmic Ocu-Phrin Sterile Eye Drops Ophthalmic
Some commonly used brand names are: In the U.S.— Ak-Dilate Ak-Nefrin Dilatair I-Phrine Isopto Frin Mydfrin Neofrin Neo-Synephrine Ocugestrin Ocu-Phrin Sterile Eye Drops Ocu-Phrin Sterile Ophthalmic Solution Phenoptic Prefrin Liquifilm Relief Eye Drops for Red Eyes In Canada— Ak-Di more...

Oxiconazole Lotion Oxiconazole Lotion
Generic Name: Oxiconazole Lotion (ox-ee-KON-uh-zole) Brand Name: OxistatOxiconazole Lotion is used for:Treating fungal infections, such as athlete's foot, jock itch, and ringworm. It may also be used for other conditions as determined by your doctor. Oxiconazole Lotion is an antifungal. It works more...